This neuroprotective mechanism does not seem specific for MS, but rather a general response to CNS damage, as ADM concentration is also elevated in the CSF after traumatic brain injury [62] and in ageing cortex [38]. The gene discussed is ADM; the disease is myeloid sarcoma.